Sell-Side Analyst: 2026 IB Career Guide From Day 1 to Exit
A sell-side analyst is a research professional at an investment bank or equity research firm who publishes buy, sell, and hold ratings on listed companies and distributes that work to institutional clients (mutual funds, hedge funds, pension managers). The “sell-side” label refers to the firm selling research and trading services to investors. Most candidates searching the term mean the equity research role at firms like Goldman Sachs, Morgan Stanley, JPMorgan, Jefferies, or William Blair, where you cover 10 to 25 names, build models, host management meetings, and publish notes that drive client trading flow.
The phrase has a second meaning that confuses early-career candidates. A “sell-side analyst” can also refer to a first-year M&A banker working sell-side engagements, which means representing a corporate or private equity seller in a transaction. That job lives inside the investment banking division (IBD), pays differently, has a different lifestyle, and routes to a different set of exits. We address both roles below, but the bulk of this guide focuses on equity research because that is what 80 percent of searches mean according to keyword intent data from Ahrefs and Semrush sector reports.
This guide covers the daily workflow, tier-1 firms hiring in 2026, full compensation benchmarks from analyst through MD, how the role compares to a buy-side seat at a hedge fund or long-only manager, common exits, how to break in, the regulatory framework, and the structural shifts reshaping the industry through MiFID II unbundling and AI-assisted note writing.
Sell-side analyst vs sell-side IB junior: the two roles behind the same phrase
The two jobs share a phrase and almost nothing else. Understanding the split before you apply, recruit, or accept an offer saves real money and years of misallocated effort.
An equity research analyst sits inside the research division of a sell-side firm. The job is to cover a list of listed equities, build maintenance models, publish initiation reports and earnings notes, host or attend management roadshows, and field calls from buy-side portfolio managers and analysts who consume the research. You publish under your own name, your ratings get tracked by services such as Institutional Investor All-America Research Team and TipRanks, and your compensation correlates with rankings, votes from clients, and trading commissions your sector generates.
A sell-side investment banking analyst sits inside IBD. The job is to support managing directors and vice presidents executing M&A transactions, equity offerings, and debt issuances. A “sell-side mandate” in this context means the firm has been hired by a company or a private equity sponsor to sell an asset. You build the operating model, the discounted cash flow, the LBO case, the comparable company set, draft the confidential information memorandum, manage the data room, and process bids. You do not publish public ratings. Your name does not appear on the work.
The decision tree is straightforward. If you want to write and speak publicly about companies and stocks, want a sector specialty, want to be evaluated by named buy-side accounts, and prefer a 60 to 80 hour week with weekend reading rather than weekend work, equity research is the seat. If you want transactional reps, want to learn LBO and M&A mechanics inside live deals, want a clean lateral path into private equity, growth equity, or corporate development, and accept 80 to 100 hour weeks for two to three years, IBD sell-side is the seat. Compensation overlaps at the top but the slope is different, as we show in section 5.
The tier-1 firms for equity research in 2026 are the bulge brackets (Goldman Sachs, JPMorgan, Morgan Stanley, Bank of America, Wells Fargo, Citi), the elite middle market (Jefferies, William Blair, Stifel, Raymond James, Robert W. Baird, Wedbush), and the specialist boutiques (AB Bernstein under Societe Generale since 2024, Evercore ISI, Oppenheimer, Piper Sandler, Cowen now part of TD Securities since 2023). For sell-side IBD, the same firms plus the M&A boutiques (Centerview, Lazard, PJT Partners, Moelis, Houlihan Lokey, Guggenheim).
Equity research analyst day-in-the-life during earnings season
Earnings season runs four times a year, roughly two weeks in January, April, July, and October, and during those windows a sell-side analyst lives at the desk. The pace compresses every other workflow into the gaps.
A typical earnings-day morning starts at 6 a.m. on the Bloomberg terminal. You scan overnight European trades on dual-listed names, parse the company press release the second it crosses the wire, plug the reported figures into the maintenance model, compare to your published estimate and the Visible Alpha consensus, and draft a one-page “reaction note” with three bullets: beat or miss versus consensus, the two or three drivers behind it, and your view on whether the print changes the multiple. The note has to be cleared by your associate director of research and your compliance officer before it hits the distribution list, which is typically a window of 30 to 60 minutes between the release and the 8:30 a.m. ET earnings call.
The earnings call itself runs 60 to 90 minutes. You queue for a question in the analyst Q&A, listen for guidance changes, and capture management body language on any controversial topic. By 10 a.m. you are rebuilding the out-year model with new guidance, updating the comparable set, and writing the “earnings recap” note that is the deliverable buy-side clients expect by end of day. Voicemails from portfolio managers stack up from 11 a.m. forward and most analysts return them in batches between meetings.
Afternoons in earnings season are client calls. You host two to five 30-minute calls per day with named buy-side accounts, walking them through your read on the print and your revised numbers. Many of those calls are recorded by the buy-side firm and tagged in their own compliance system. Late afternoon is when you cut the note to its final form, reconcile your forecast to the new consensus once it has reset, and queue tomorrow’s coverage.
Outside earnings season the pace shifts to channel checks, expert calls through Tegus, GLG, AlphaSense, and Third Bridge, primary research surveys, sector conferences, and initiation reports for new coverage names. A high-conviction initiation runs 40 to 80 pages over four to eight weeks. Read the WSJ “Heard on the Street” column or Bloomberg Intelligence sector dashboards to see finished published output.
Tier-1 sell-side research firms 2026: bulge bracket, middle market, boutique
The competitive set has consolidated since 2018 but the tier structure is intact. Where you start sets your access to issuer management teams, your model rigor expectations, and your downstream exit options.
| Tier | Firms (2026) | Coverage breadth | Typical analyst comp Y1 (base + bonus) |
|---|---|---|---|
| Bulge bracket | Goldman Sachs, JPMorgan, Morgan Stanley, Bank of America, Wells Fargo, Citi | Global, full sector coverage, 600+ ranked analysts firm-wide | $135-150k base + $30-100k bonus |
| Elite middle market | Jefferies, William Blair, Stifel, Raymond James, Robert W. Baird, Wedbush, Piper Sandler | US-focused with selective international, deep sector specializations | $120-140k base + $25-75k bonus |
| Boutique specialist | AB Bernstein (SocGen since 2024), Evercore ISI, Oppenheimer, BTIG, TD Cowen (TD Securities since 2023) | Sector-deep, fewer names per analyst, top-ranked notes | $130-150k base + $30-90k bonus |
Bulge brackets win the heaviest trading flow, host the largest investor conferences (the Goldman Communacopia + Technology Conference, JPMorgan Healthcare Conference, Morgan Stanley TMT, BofA Auto Summit), and route the most volume into capital markets cross-sell. The downside is the matrix structure: at a bulge a Year-1 analyst frequently sits on a team of three or four under a senior analyst and writes only secondary product for the first 18 months.
Middle-market firms run leaner teams. At William Blair, Stifel, and Robert W. Baird a Year-1 analyst is often the only junior under a senior, which means you write your own initiations within 12 to 18 months and your name appears on published notes earlier. Trade-off is fewer high-profile names. Middle-market firms historically dominate the Greenwich Associates Equity Trading Research Survey among small and mid-cap buy-side accounts.
Boutiques are sector-deep. AB Bernstein consistently ranks at the top of the Institutional Investor All-America Research Team survey across multiple sectors, with the 2024 results showing Bernstein placing first or second in seven sectors and the 2025 results extending that lead in technology, semiconductors, and consumer staples. Evercore ISI built its franchise around the macro and policy team led by Ed Hyman, who has topped the II macro rankings for 40-plus consecutive years per Institutional Investor archives. TD Cowen (renamed after TD Securities acquired Cowen in 2023) leads in biotech and healthcare.
The II rankings matter to your career economics. A First Team ranking is worth $200-600k in incremental bonus depending on firm, per industry compensation surveys from Selby Jennings and Heidrick & Struggles, because it triggers higher commission allocations from buy-side accounts in the next year’s voting cycle.
Compensation: analyst, associate, VP, MD pay benchmarks 2026
Sell-side equity research compensation is a base-plus-bonus structure with the bonus tied to a mix of personal ranking, sector revenue contribution, and firm-wide research department performance. Numbers below are 2025 calendar-year benchmarks reported in the most recent Selby Jennings 2025 IB Compensation Survey, Heidrick & Struggles 2024 Financial Services Compensation Report, and aggregated Wall Street Oasis equity research compensation threads through Q1 2026.
| Level | Years experience | Base salary | Bonus range | Total comp range |
|---|---|---|---|---|
| Analyst Y1 | 0-1 | $135-150k | $30-100k | $165-250k |
| Analyst Y2-3 | 1-3 | $150-180k | $50-150k | $200-330k |
| Senior Associate | 3-5 | $200-275k | $75-275k | $275-550k |
| VP / Sector Head | 5-9 | $325-500k | $200-700k | $525k-1.2M |
| Director / Sr Sector Head | 9-13 | $500-700k | $400-1.5M | $900k-2.2M |
| Managing Director | 13+ | $1M-3M+ guarantee | $500k-5M+ | $1.5M-8M+ |
A Year-1 sell-side analyst at a bulge bracket pulls $165-250k all-in versus $180-300k for a first-year IBD analyst per WSO 2025 IB Comp Report. The gap narrows by Year 3 and reverses in senior years if the research analyst climbs into II rankings.
The bonus structure deserves a closer look. At a bulge bracket the bonus pool for the entire research department is sized as a percentage of sales and trading commissions plus a corporate allocation. The director of research distributes the pool based on a scorecard: II votes, Greenwich Survey votes, internal trading-desk feedback on idea generation, written-product quality, and management access value (how many CEO and CFO meetings you set up for clients). A median ranked Year-1 analyst pulls $50-75k bonus. A First Team Year-1 (rare but possible if you joined a star team) pulls $100k-plus.
Top-tier outliers exist. A Hall of Fame senior analyst who has held a First Team II ranking for a decade in a high-commission sector (semiconductors, internet, biotech, large-cap pharma) can pull $2-5M annual base plus bonus, with the upper tier of $5-10M reserved for franchise names like Toni Sacconaghi (Bernstein hardware), Mary Meeker (formerly Morgan Stanley internet, now Bond Capital), or the late Ed Hyman tier at Evercore ISI. Those are 1-percent-of-the-profession outcomes, not the median.
Compare against buy-side. A Year-1 hedge fund analyst at a multi-manager platform like Citadel, Millennium, Point72, or Balyasny pulls $200-500k cash compensation, per Coalition Greenwich 2024 buy-side comp data and platform-specific surveys reported by eFinancialCareers. Year 3-5 hedge fund analysts on a winning pod pull $500k-2M with carry exposure. PE associates pull $250-400k base plus bonus plus carry vesting, per Heidrick 2024 PE Comp Report. The trade-off across the lifetime path is covered in section 7.
Weekly workflow: modeling, writing, channel checks, and the MiFID II shadow
Outside earnings season the rhythm is weekly rather than daily. A typical sector analyst at a bulge or elite middle-market shop covers 15 to 25 names, runs a Monday-morning sector pre-read for the sales force, publishes one or two “thematic” or company-specific notes per week, hosts client calls in the afternoons, and travels for management meetings, conferences, or buy-side marketing roughly 30 percent of the year.
Modeling is the foundation. The maintenance model is a rolling four-to-eight-quarter forward forecast with segment-level revenue drivers, gross margin walk, operating expense build, and a clean GAAP-to-non-GAAP reconciliation. You update the model after every earnings print, every guidance revision, every material data point (channel check, expert call, competitor print). Valuation is typically a sum-of-the-parts (for multi-segment names), a discounted cash flow as a cross-check, and a relative multiple framework (forward EV/EBITDA, P/E, EV/sales, and sector-specific metrics like price-to-NAV for REITs, price-to-book for banks, or EV/reserves for E&P).
Note writing is the deliverable. The published forms are the initiation report (20-80 pages, the first time you publish on a name, includes investment thesis, competitive positioning, model walkthrough, risks, valuation, and price target), the earnings reaction note (1-3 pages, hits the wire within 60 minutes of the print), the thematic note (5-15 pages, sector or topic specific, used to drive marketing meetings), and the quick update (1 page, on a guidance revision, M&A announcement, or material news). Each format has a templated structure enforced by the firm’s research compliance team.
Client outreach is the part of the job business school does not teach. You build a target account list with the sales team, request meetings, host calls, attend buy-side analyst dinners, and explicitly market your published views. The vote-driven economics mean a sector head is functionally running a small services business: 30 to 60 buy-side relationships, each evaluated quarterly on the call-to-vote conversion rate.
Channel checks supplement the published numbers. You survey distributors, customers, suppliers, and former employees through expert networks. Tegus alone has built a library of 50,000-plus expert call transcripts as of 2025 per its corporate disclosures, which has compressed the time and dollar cost of channel work but raised the bar on differentiation. Best-in-class analysts run proprietary surveys (consumer panels through Numerator or Nielsen, B2B surveys through Civis Analytics) to generate data the competing notes do not have.
MiFID II is the structural shadow over the workflow. The European Union’s Markets in Financial Instruments Directive II took effect in January 2018 and required asset managers to pay for research separately from execution commissions, ending the implicit bundling that funded sell-side research for decades. The European Securities and Markets Authority revised the rules in 2024 to allow rebundling for SME research, but US asset managers still mostly operate under cash payment models. The SEC permitted a “no action” relief letter for US brokers from 2017 through July 2023 letting them receive hard-dollar payments from EU clients without becoming registered investment advisers; the relief expired and the SEC declined to extend it, forcing structural changes. The net effect: global sell-side research headcount has shrunk roughly 35 percent from the 2008 peak per Frost Consulting research industry reports, with the cuts concentrated in mid-tier shops.
Buy-side vs sell-side analyst: which seat for which career
Most equity research analysts make a buy-side move within four to seven years of starting. Understanding the structural differences before you switch reduces the chance of a wrong fit.
| Dimension | Sell-side analyst | Buy-side analyst (HF / long-only / PE public-markets) |
|---|---|---|
| Names covered | 15-25 per sector | 5-15 deep coverage; 30+ tracked |
| Published output | 1-3 notes per week | Internal memos only, not public |
| Time on client calls | 30-40% of week | 5-10% (only senior reach-out) |
| Modeling depth | Segment-level forecast, multi-valuation | Deeper, often with scenario weightings and probability-adjusted price targets |
| Skin in the game | Bonus tied to votes, rankings, sector revenue | Direct P&L attribution; carry or P&L share |
| Year-1 cash comp | $165-250k | $200-500k (HF pod), $150-300k (long-only) |
| Hours | 60-80 per week | 60-75 long-only; 65-85 HF |
| Travel | 30% of year (conferences, marketing) | 10-15% (earnings, expert calls in person) |
| Career risk | Vote-driven; sector cuts during downturns | P&L driven; pod analysts can be cut for a single bad year at multi-managers |
Hedge fund pods at Citadel, Millennium, Point72, Balyasny, ExodusPoint, and Schonfeld pay the highest Year-1 to Year-3 cash comp on the buy-side: $200-500k at junior analyst level and $500k-2M for proven coverage analysts per eFinancialCareers buy-side pay data 2025. The trade-off is concentrated career risk: pods that post a negative year are often cut, and individual analyst tenure at multi-managers averages 18 to 30 months.
Long-only managers (Fidelity, T. Rowe Price, Wellington, Capital Group, Dodge & Cox, MFS) pay lower cash comp but offer longer tenure and less P&L pressure. A senior research analyst at Fidelity or Wellington with 15-plus years tenure routinely pulls $750k-2M annual including deferred compensation per Greenwich Associates asset management survey data.
Private equity public-markets seats (Blackstone Public Equity, KKR Public Markets, Apollo S3, Carlyle Public Solutions, sovereign wealth equity teams) pay $250-500k Year-1 with carry and have grown rapidly since 2022. PE associate seats focused on private deals pay $250-400k cash plus carry that can vest into seven figures per Heidrick & Struggles PE comp 2024.
Common exit paths and the actual distribution
Sell-side equity research analysts exit at predictable points: end of Year 2 (most common, before associate promotion), end of Year 3-4 (after building publishing record), and end of Year 6-8 (after senior associate or VP promotion, with a sector specialty established).
The destination distribution from aggregated WSO career outcome data, LinkedIn cohort analyses of bulge-bracket research alumni from 2015 to 2022, and the Coalition Greenwich talent flow reports breaks down approximately as follows. Roughly 45 percent move to a hedge fund, with multi-manager pods (Citadel, Millennium, Point72) accounting for the largest share inside that bucket. Roughly 15 percent move to long-only mutual fund managers (Fidelity, T. Rowe Price, Wellington, Capital Group). Roughly 10 percent move to corporate roles, most often Investor Relations at a company they previously covered, FP&A, or Corporate Development. Roughly 8 percent move to private equity public-markets or hybrid funds. Roughly 5 percent move to strategy consulting (McKinsey, Bain, BCG, often into the financial institutions practice). Roughly 5 percent move to founding or joining an operating company. The remaining 12 percent stay in research, either at the same firm climbing toward MD or at a competitor for a senior seat.
The Investor Relations exit is underappreciated. A senior research analyst who covered a name for five-plus years has more cumulative knowledge of that company’s investor base than the company’s own treasurer. Companies pay $250-500k base plus stock for an IR head from the sell-side, with 40-50 hour weeks typical.
Corporate Development is the second underappreciated exit. Reading and writing CIMs, evaluating acquisitions, and building the LBO inside a strategic acquirer is the natural pivot for an analyst who learned M&A grammar by watching competitors in their sector. Comp at Corp Dev VP level is $300-500k base plus stock plus bonus per Association for Corporate Growth surveys.
The founder path is uncommon but real. Henry Blodget covered internet stocks at Merrill before launching Business Insider; Mary Meeker built her VC career at Bond Capital on the internet coverage franchise she ran at Morgan Stanley. The pattern: build a sector network, identify an unmet need, convert the network into customers or co-investors.
How to break in: target schools, certifications, internships, and interview tactics
Equity research recruits from a narrower funnel than IBD. The funnel pulls heavily from undergraduate finance and accounting programs at Wharton, NYU Stern, Notre Dame Mendoza, Michigan Ross, UVA McIntire, UNC Kenan-Flagler, Indiana Kelley, Cornell Dyson, and Georgetown McDonough, plus the MBA programs at Harvard, Wharton, Booth, Sloan, Columbia, Tuck, Stern, Haas, Yale, and Kellogg. Specialty programs that punch above their weight include the Yale SOM Asset Management track, the Stanford GSB finance majors, and the MIT Sloan Master of Finance.
The CFA charter is helpful but not mandatory. A passed Level 2 is what most sell-side hiring managers want to see on a junior resume. Level 3 and full charter status are correlated with senior promotions but not required to enter. Plan on 300 study hours per level per the CFA Institute’s published guidance.
Series licenses are mandatory. You need FINRA Series 7 (general securities representative), Series 63 (state regulation), Series 86 (research analyst analytical), and Series 87 (research analyst regulatory). Firms sponsor and pay for these. The 86 is the hardest, structured as a four-hour exam covering financial statement analysis, valuation, and quantitative methods.
The internship path matters more than for IBD because the analyst hiring class for research at any given firm is small (15-40 hires at a bulge bracket research division versus 80-150 in IBD). Summer Analyst programs at Goldman, Morgan Stanley, JPMorgan, Bank of America, Citi, Jefferies, William Blair, and Stifel are the dominant funnel. Conversion rates from SA to full-time offer typically run 70-85 percent per firm-disclosed metrics and aggregated WSO surveys. Apply 12 to 18 months ahead of the summer.
Interview tactics differ from IBD. The technical questions are 60 percent valuation, 30 percent accounting and financial statement analysis, and 10 percent macro and sector knowledge. The behavioral questions emphasize “why this sector” specifically, why research rather than banking, and how you would pitch a stock. The expected output is a “stock pitch” you have prepared on a publicly traded company: 5-10 minute walk-through covering thesis, model summary, valuation, and risks. Mergers & Inquisitions sell-side analyst interview guide and the WSO equity research forum are the working syllabi.
Read 100 sell-side initiation notes before your interviews. Bloomberg, FactSet, Refinitiv, and S&P Capital IQ aggregate published research. Many libraries and university Bloomberg terminals provide access. The notes teach you the tone, the structure, and the depth of analysis the seat demands faster than any classroom course.
Hour-by-hour Monday during earnings: a worked example
The single most useful exercise for a candidate weighing the role is to walk through an actual day. Below is a representative Monday during Q3 2025 earnings season for a Year-2 analyst at an elite middle-market shop covering 18 software names, two of which report Monday afternoon.
6:30 a.m. ET: Bloomberg terminal up. Scan overnight European software trades and US futures. Read three sector-relevant news items from The Information and Bloomberg Tech Daily. Check overnight email for buy-side requests. 7:00 a.m.: Pre-market team huddle by Bloomberg Chat with the senior analyst, associate, and sales force trader. Walk through expected prints and the consensus setup for the two reporting names. 7:30 a.m.: Finish the maintenance model “what’s priced in” sensitivity table that goes into the morning client note. Send to associate for review.
8:00 a.m.: Morning note publishes to clients. 8:30 a.m. to 9:30 a.m.: First-name earnings call. Sit on Q&A queue. Take notes on revenue mix, gross margin, sales cycle commentary. 9:30 a.m. to 10:30 a.m.: Rebuild model with reported figures and revised guidance. Cross-check the press release reconciliation tables. Send draft revised model to associate director for cap-table sanity check. 10:30 a.m. to 11:30 a.m.: Draft earnings reaction note. Three bullets: print versus consensus, the two key drivers, view on whether the multiple should expand or compress. Send to compliance review.
11:30 a.m. to 1:30 p.m.: Client calls. Three 30-minute calls with named portfolio managers at large mutual funds and one hedge fund. Walk through the print, the model implication, and your revised price target. 1:30 p.m. to 3:30 p.m.: Channel checks for the second reporting name. Two Tegus expert calls scheduled with former divisional VPs at competitor firms. 3:30 p.m. to 4:00 p.m.: Re-read the consensus dashboard on Visible Alpha for the second name. Update your own published estimate.
4:00 p.m. to 5:30 p.m.: Second-name print drops at 4:05 p.m. Rebuild the same workflow as the morning. 5:30 p.m. to 6:30 p.m.: Second-name earnings call. 6:30 p.m. to 8:30 p.m.: Draft second reaction note. Send to compliance. 8:30 p.m. to 9:30 p.m.: Voicemails. Return six buy-side calls in batches. 9:30 p.m. to 10:00 p.m.: Clear inbox, set Tuesday calendar, leave the office.
Weekly average during earnings: 70-80 hours. Weekly average outside earnings: 55-65 hours. Compare to the 80-110 hour weeks reported in investment banking associate seats during live deals and you can see why research is sometimes called “the calmer side of the street,” but only if you can sustain four high-intensity weeks per quarter without burning out.
Regulatory landscape: FINRA Rule 2241, Reg AC, Reg FD, and the Global Research Settlement legacy
Sell-side research operates inside a layered regulatory framework built primarily after the dot-com era research scandals of 2001-2003. Understanding the rules is part of the job and your Series 86 and 87 exams test you on the specifics.
FINRA Rule 2241 governs equity research analyst conflicts of interest. The rule mandates structural separation between research and investment banking divisions, prohibits research compensation tied to specific banking deals, requires written firm policies on coverage initiation and termination, mandates disclosure of ownership positions and any banking relationships in published reports, and restricts pre-publication communication between research analysts and banking personnel on covered names. The rule was last amended in 2015 with technical updates and remains the primary conduct rule.
SEC Regulation Analyst Certification (Reg AC) requires every published research report to include a certification by the research analyst that the views expressed reflect the analyst’s personal opinion and that no part of the analyst’s compensation was directly or indirectly related to the specific recommendations or views in the report. Reg AC has been in effect since April 2003.
SEC Regulation Fair Disclosure (Reg FD) prohibits issuers from selectively disclosing material non-public information to securities professionals, including sell-side research analysts. The rule, in effect since October 2000, ended the historical practice of analysts getting earnings guidance ahead of public release and is why the modern channel-check and expert-call infrastructure (Tegus, GLG, AlphaSense) exists.
The Global Research Settlement of April 2003 (formally the Global Analyst Research Settlements) resolved enforcement actions against ten major firms for fraudulent research practices during the dot-com era. The settlement required $1.4 billion in penalties, mandated structural research-banking separation that became FINRA Rule 2241, funded independent research, and imposed five-year retention of independent research consultants. The legacy: every sell-side firm operates under physical-layout, supervisory, and compensation structures designed to prevent the conflicts the settlement exposed.
The supervisory expectation: every published note runs through compliance review for fact-check, disclosure adequacy, and ratings consistency. Most firms add a peer-review layer where a second analyst signs off on the model and a director of research signs off on the rating change. Initiation lead times run two to four weeks of compliance review.
2024-2026 research industry trends: AI, MiFID II aftermath, expert networks, in-house competitors
Four structural shifts are reshaping the seat between now and 2027. Each affects the headcount, the workflow, and the compensation outlook.
AI-assisted note writing is moving fast. Goldman Sachs, Morgan Stanley, and JPMorgan have all publicly disclosed internal AI tools for first-draft note generation, model auto-population from earnings transcripts, and consensus-comparison summaries. Morgan Stanley’s AI @ Morgan Stanley platform launched in 2023 and was extended to research workflows in 2024. JPMorgan disclosed in its 2024 annual report deploying its IndexGPT and DocLLM tools across the research division. The net effect for junior analysts is a shift from raw drafting to editorial and analytical work. Some industry observers (see the Frost Consulting industry reports 2024-2025) project a further 10-15 percent reduction in junior research headcount through 2027 as the tools mature.
MiFID II permanent shrinkage. Global sell-side research budgets are down approximately 35 percent from 2008 peak per Frost Consulting and Coalition Greenwich tracking data. Mid-tier shops have consolidated: Cowen sold to TD Securities in 2023 for $1.3 billion, Wedbush and other mid-market firms continue exploring strategic options, and Bernstein was acquired by Societe Generale in 2024 to form AB Bernstein. The bulge and boutique top tiers have absorbed market share. Expect continued thinning at the middle.
Expert network growth. The expert-network industry has grown to over $2.5 billion in annual revenue by 2024 per AlphaSense and Third Bridge industry disclosures, with Tegus alone (acquired by AlphaSense in June 2024 for $930 million per the AlphaSense press release) building a transcript library that has commoditized basic primary research. The bar on differentiated channel work has risen: best-in-class analysts now run proprietary surveys (Civis Analytics, Numerator panels, Datassential for restaurants) to generate genuinely unique data.
In-house buy-side competition. Bloomberg Intelligence has scaled to over 500 research analysts globally as of late 2024 per Bloomberg LP disclosures, sitting between sell-side and pure independent research, and offering buy-side clients an unbundled subscription product that competes directly with sell-side note distribution. Independent research shops (Gordon Haskett, MoffettNathanson which merged with SVB Leerink in 2022, Wolfe Research, and the boutique sector specialists) have taken share from mid-tier sell-side. The structural trend favors the very top of the bulge stack and the genuinely differentiated boutique seat; the middle continues to compress.
The career implication is straightforward. If you can land a seat at a top-of-stack bulge or a top-five boutique in your sector, the long-term career economics still work. If your offer is at a mid-tier shop without a clear path to a star senior analyst, plan the buy-side exit by Year 3.
Sector specialization: which coverage groups pay best and exit cleanest
Not every sector inside a research division has equal economics. Commission flow, investor interest, deal volume, and buy-side voting concentration drive a clear hierarchy that affects your bonus, your exit options, and your career path.
Technology, biotech, and internet are the perennial top-paying sectors. The reason is mechanical: tech and biotech generate disproportionate trading volume relative to market cap, draw a deep specialist hedge-fund customer base, and produce frequent IPO and follow-on fee events. The top-ranked semiconductor analyst at AB Bernstein, the top internet analyst at Morgan Stanley, and the top biotech analyst at TD Cowen routinely sit in the top five firm-wide compensation seats per surveys from eFinancialCareers and Selby Jennings.
Financials, large-cap consumer, and energy form the second tier. Coverage is heavier on macro context, regulatory analysis, and commodity modeling, which lengthens the apprenticeship but produces analysts with skill sets transferable to corporate strategic finance seats. Industrials, materials, REITs, and utilities are the slower-tempo end: lower trading volume, longer report lead times, fewer IPOs, but consistent commission flow from generalist long-only accounts. Compensation tracks 70-85 percent of tech-and-biotech levels at the same firm rank, and the exit pattern is heavier into corporate roles (IR, FP&A, treasury) and into long-only buy-side rather than hedge fund pods.
The practical implication when choosing among offers: evaluate the sector and the senior analyst, not just the firm name. A Year-1 seat at a mid-tier shop covering a hot tech subsector under a First Team II senior can outperform a bulge bracket seat under a generalist senior over a five-year horizon. Ask the question on the offer call: which sector, which senior, what is the team’s most recent II ranking trend.
Building a stock pitch: the deliverable that gets you hired
Every junior hire into sell-side research is expected to walk into the final-round interview with one or two prepared stock pitches. The pitch is the single most evaluated artifact in the hiring funnel and a strong pitch in a final-round superday is the most common reason a borderline candidate gets the offer.
The expected structure is consistent across bulge and elite middle market: a five-to-ten-minute oral walkthrough covering the investment thesis (one sentence), the variant view (what the market has wrong), the model summary (top-line growth, margin trajectory, capital allocation), the valuation framework (multi-method), the price target with timing, the catalysts, and the three primary risks with falsifying data.
Choose a publicly traded mid-cap or large-cap in a sector you can sustainably study. Avoid mega-cap names like Apple, Microsoft, or NVIDIA because every candidate pitches them and your differentiation has to be implausibly sharp. Pick a name with a clear catalyst path and a defensible valuation gap. The CFA Institute publishes free refreshers walking through pitch frameworks. Read 20 to 30 published sell-side initiation reports before drafting your own; mirror their structure.
Common mistakes: overweighting macro and underweighting company-specific drivers, building a price target on a single valuation method, citing consensus without explaining how your view differs. The interviewer’s first question is “what does the market have wrong here.” If you cannot answer in one sentence, the thesis is not differentiated enough.
TLDR and seven takeaways if you are considering the role
You came to this article either because you are weighing a sell-side analyst offer, you are recruiting and want to compare to IBD or buy-side, or you are a buy-side analyst evaluating a senior sell-side lateral. Here are the seven highest-impact facts.
- Two roles share the name. 80 percent of “sell-side analyst” queries mean equity research analyst at a sell-side firm. The other 20 percent mean a first-year IBD analyst working sell-side M&A engagements. Different careers, different exits, different comp slopes.
- Comp is good but not IBD-level Year 1. Year 1 sell-side research pulls $165-250k all-in versus $180-300k for IBD. By Year 3-5 the gap closes and reverses if you land in II rankings. Senior MDs at the top of the II rankings pull $2-8M; that is rare.
- Hours are 60-80 versus IBD 80-110. The trade-off is real but earnings season compresses four weeks per quarter into 70-80 hour grinds.
- MiFID II shrunk the industry 35 percent from 2008 peak. The bulge bracket top and the boutique specialist top have absorbed share. Mid-tier shops continue to consolidate. Pick your seat with the structural shift in mind.
- The most common exit is hedge fund (45 percent). Multi-manager pods at Citadel, Millennium, Point72 pay $200-500k Year 1 with $500k-2M by Year 3 if your pod posts. Higher upside, higher career risk.
- Underappreciated exits: IR and Corp Dev. If you cover a sector for five years you know your covered companies’ business better than their CFOs. IR head and Corp Dev VP roles pay $250-500k base plus stock with 40-50 hour weeks.
- The seat is hardest in years 1-3 and best in years 5-9. The grind years build the model and writing fluency. The sweet spot is the senior associate to VP window when you publish under your own name, build a vote base, and decide whether to climb to MD or take the buy-side exit.
If you want to compare the path against private equity, read our private equity analyst career guide. If you are weighing the IBD path, read why investment banking as a career and the investment banking associate career guide. If you are deciding between research and a hedge fund seat directly, read our hedge fund versus investment bank career comparison.